January 25, 2017
This policy brief describes the challenges large employers face in managing high-priced specialty drugs, examines ways to better manage them and offers public policy recommendations that would create a more favorable environment for financial sustainability and affordability of these medications.
Policy Recommendations to Promote Sustainable, Affordable Pricing for Specialty Pharmaceuticals
More TopicsArticles & Guides Plan Design & Administration COVID-19
This content is for members only. Already a member? Login